[Development antihyperuricemic candidates].
Yamamoto
Tetsuya
T
Department of Internal Medicine, Hyogo College of Medicine.
D000818:Animals; D015195:Drug Design; D004791:Enzyme Inhibitors; D000069465:Febuxostat; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy*; D011720:Pyrazoles; D013777:Tetrazoles; D013844:Thiazoles; D014503:Urate Oxidase; D014528:Uricosuric Agents; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
C433950:1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid; D004791:Enzyme Inhibitors; D011720:Pyrazoles; D013777:Tetrazoles; D013844:Thiazoles; D014528:Uricosuric Agents; C469709:rasburicase; D000069465:Febuxostat; D014969:Xanthine Oxidase; D014503:Urate Oxidase